Skip to main content

and
  1. No Access

    Protocol

    Gene Editing in Mouse Zygotes Using the CRISPR/Cas9 System

    Engineering of the mouse germline is a key technology in biomedical research for studying the function of genes in health and disease. Since the first knockout mouse was described in 1989, gene targeting was b...

    Benedikt Wefers, Wolfgang Wurst, Ralf Kühn in Transgenesis (2023)

  2. Article

    Open Access

    Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation

    Bacterial cell wall components provide various unique molecular structures that are detected by pattern recognition receptors (PRRs) of the innate immune system as non-self. Most bacterial species form a cell ...

    Che A. Stafford, Alicia-Marie Gassauer, Carina C. de Oliveira Mann in Nature (2022)

  3. No Access

    Article

    Simple and reliable detection of CRISPR-induced on-target effects by qgPCR and SNP genoty**

    The recent CRISPR revolution has provided researchers with powerful tools to perform genome editing in a variety of organisms. However, recent reports indicate widespread occurrence of unintended CRISPR-induce...

    Isabel Weisheit, Joseph A. Kroeger, Rainer Malik, Benedikt Wefers in Nature Protocols (2021)

  4. Article

    Open Access

    The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions

    Microglia-specific genetic variants are enriched in several neurodegenerative diseases, including Alzheimer’s disease (AD), implicating a central role for alterations of the innate immune system in the disease...

    Mari Takalo, Rebekka Wittrahm, Benedikt Wefers in Molecular Neurodegeneration (2020)

  5. Article

    Open Access

    Congenic expression of poly-GA but not poly-PR in mice triggers selective neuron loss and interferon responses found in C9orf72 ALS

    Expansion of a (G4C2)n repeat in C9orf72 causes amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), but the link of the five repeat-encoded dipeptide repeat (DPR) proteins to neuroinflammation,...

    Katherine D. LaClair, Qihui Zhou, Meike Michaelsen in Acta Neuropathologica (2020)

  6. Article

    Open Access

    The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans

    The R47H variant of the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) significantly increases the risk for late onset Alzheimer’s disease. Mouse models accurately reproducing phenotypes observed in ...

    **anyuan **ang, Thomas M. Piers, Benedikt Wefers in Molecular Neurodegeneration (2018)

  7. Article

    Erratum: Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells

    Nat. Biotechnol. 33, 543–548 (2015); published online 24 March 2015; corrected after print 14 December 2017 In the version of this article initially published, in the HTML only, in Online Methods “Cell culture...

    Trung Van Chu, Timm Weber, Benedikt Wefers, Wolfgang Wurst in Nature Biotechnology (2018)

  8. No Access

    Article

    Control of gene editing by manipulation of DNA repair mechanisms

    DNA double-strand breaks (DSBs) are produced intentionally by RNA-guided nucleases to achieve genome editing through DSB repair. These breaks are repaired by one of two main repair pathways, classic non-homolo...

    Eric Danner, Sanum Bashir, Saniye Yumlu, Wolfgang Wurst in Mammalian Genome (2017)

  9. No Access

    Book

  10. No Access

    Protocol

    Genome Editing in Mice Using TALE Nucleases

    Gene engineering for generating targeted mouse mutants is a key technology for biomedical research. Using TALENs as sequence-specific nucleases to induce targeted double-strand breaks, the mouse genome can be ...

    Benedikt Wefers, Christina Brandl, Oskar Ortiz, Wolfgang Wurst, Ralf Kühn in TALENs (2016)

  11. No Access

    Article

    Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells

    The efficiency of precise CRISPR/Cas9 genome editing is increased by inhibition of the nonhomologous end joining pathway.

    Van Trung Chu, Timm Weber, Benedikt Wefers, Wolfgang Wurst in Nature Biotechnology (2015)

  12. No Access

    Article

    Generation of targeted mouse mutants by embryo microinjection of TALEN mRNA

    Genetically engineered mice are instrumental for the analysis of mammalian gene function in health and disease. As classical gene targeting, which is performed in embryonic stem (ES) cell cultures and generate...

    Benedikt Wefers, Sudeepta K Panda, Oskar Ortiz, Christina Brandl in Nature Protocols (2013)

  13. No Access

    Article

    Gezielte Manipulation des Genoms mit Zinkfingernukleasen

    In vielen Säugetierarten gab es bis jetzt keine effektiven Werkzeuge für eine gezielte Genmodifikation. Die Entwicklung der Zinkfingernuklease-Technologie ermöglicht nun auch in diesen Organismen eine schnelle...

    Melanie Meyer, Benedikt Wefers, Oskar Ortiz, Wolfgang Wurst, Ralf Kühn in BIOspektrum (2011)

  14. No Access

    Protocol

    Generating Conditional Knockout Mice

    Gene targeting in ES cells is extensively used to generate designed mouse mutants and to study gene function in vivo. Knockout mice that harbor a null allele in their germline provide appropriate genetic models o...

    Roland H. Friedel, Wolfgang Wurst in Transgenic Mouse Methods and Protocols (2011)

  15. Article

    Local Knockdown of ERK2 in the Adult Mouse Brain Via Adeno-Associated Virus-Mediated RNA Interference

    Barbara Di Benedetto, Benedikt Wefers, Wolfgang Wurst, Ralf Kühn in Molecular Biotechnology (2009)

  16. Article

    Open Access

    Local Knockdown of ERK2 in the Adult Mouse Brain Via Adeno-Associated Virus-Mediated RNA Interference

    In recent years RNA interference (RNAi) has become a useful genetic tool to downregulate candidate disease genes for which pharmaceutical inhibitors are not available. In combination with viral vectors to trig...

    Barbara Di Benedetto, Benedikt Wefers, Wolfgang Wurst, Ralf Kühn in Molecular Biotechnology (2009)